← Open Payments lookup

MATTHEW OSENBAUGH: Open Payments

NPI 1649587593 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,207 in 125 payments from 17 companies in 2025. Trend: 2023 $2,627 · 2024 $1,897 · 2025 $2,207

Food & beverage: $2,130Education: $77
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.21$408
ABBVIE INC.35$399
Janssen Biotech, Inc.13$307
Lilly USA, LLC11$291
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$176
Aimmune Therapeutics, Inc.5$116
Regeneron Healthcare Solutions, Inc.4$93
Madrigal Pharmaceuticals5$81
Ipsen Biopharmaceuticals, Inc4$77
Ardelyx, Inc.4$63

Products named: ENTYVIO, TREMFYA, OMVOH, XIFAXAN, DUPIXENT, ZENPEP, LINZESS, SKYRIZI.

Industry payments across KS — which companies pay providers there.